Brentuximab vedotin for frontline Hodgkin lymphoma: How much will a successful trial cost patients and payers?
- Satish Shanbhag
- , Vinay Prasad
Research output: Contribution to journal › Letter › peer-review
3
Link opens in a new tab
Scopus
citations